Past Events

January 10: Christine Zhang PhD - Washington Univerisity in St. Lious
"Mechanisms underlying the fitness advantage of Dnmt3a-mutant HSCs during inflammatory stress"

March 13: Bethany Lynn Mundy-Bosse, PhD - Ohio State University
"NK and ILC Dysregulation in Hematologic Malignancies"

April 10: Esther Obeng, MD, PhD - St. Jude Children’s Research Hospital
"The Impact of SF3B1 Mutations on Stem Cell Function and Leukemic Transformation"

May 8: Craig T. Jordan, PhD - University of Colorado
"Metabolic vulnerabilities of tumor initiating cells in myeloid pathogenesis"

May 29: Paresh Vyas, MRCP, FRCP, FRCPath - University of Oxford in Oxford, UK
"Clonal Haemopoieisis and New Immune Therapies in AML"

August 6: Melissa H. Wong, PhD - Knight Cancer Institute
"Scientific advances in the study of macrophage-tumor hybrid biology"

November 6: Ruud Delwel, PhD - Erasmus University Rotterdam, The Netherlands

January 18: Possu Huang, PhD - Stanford University

February 1: Jonathan D. Licht, MD - University of Florida Health Cancer Center

March 16: Sergei Doulatov - University of Washington

March 23: John Dick, PhD, FRS - Princess Margaret Cancer Center

April 5: Catriona Jamieson, MD, PhD - UC San Diego Health Moores Cancer Center

April 13: Andreas Trumpp, PhD - German Cancer Research Center (DKFZ)

April 16: Leroy Hood, MD, PhD - Institute for Systems Biology

June 14: Renata Pasqualini, PhD - Rutgers Cancer Institute

October 4: Jinsong Liu, MD, PhD - The University of Texas MD Anderson Cancer Center
"Decoding Cancer through Giant Cells: Towards a Coherent Comprehension of Embryogenesis and Tumorigenesis at an Organismal Scale"

October 25: Akiko Shimamura, MD, PhD - Dana Farber/Boston Children’s Cancer and Blood Disorders Center
"Genetic Predisposition to Myeloid Malignancy”

November 15: Nancy A. Speck, PhD - Abramson Family Cancer Research Institute
"Regulation of innate immunity by RUNX1"

December 7: Josh Ofman, MD, MSHS - GRAIL